JUVÉDERM SKINVIVE Trademark

Trademark Overview

On Thursday, June 10, 2021, a trademark application was filed for JUVÉDERM SKINVIVE with the United States Patent and Trademark Office. The USPTO has given the JUVÉDERM SKINVIVE trademark a serial number of 90766322. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, December 9, 2024. This trademark is owned by Allergan Holdings France SAS. The JUVÉDERM SKINVIVE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles

Apparatus, namely, injection needles and medical syringes for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

General Information

Serial Number90766322
Word MarkJUVÉDERM SKINVIVE
Filing DateThursday, June 10, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles
Pseudo MarkJUVÉDERM SKIN VIVE
Goods and ServicesApparatus, namely, injection needles and medical syringes for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 31, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllergan Holdings France SAS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCourbevoie 92400
FR
Party NameAllergan Holdings France SAS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCourbevoie 92400
FR

Trademark Events

Event DateEvent Description
Monday, June 14, 2021NEW APPLICATION ENTERED
Tuesday, August 31, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2022ASSIGNED TO EXAMINER
Tuesday, March 1, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 1, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, March 1, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 1, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 10, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 23, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 23, 2023SOU EXTENSION 2 FILED
Tuesday, May 23, 2023SOU EXTENSION 2 GRANTED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024SOU EXTENSION 4 FILED
Thursday, May 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023SOU EXTENSION 3 FILED
Thursday, November 16, 2023SOU EXTENSION 3 GRANTED
Wednesday, May 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 11, 2024SOU EXTENSION 5 FILED
Monday, November 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, December 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 10, 2024SOU EXTENSION 5 GRANTED
Tuesday, December 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024SOU EXTENSION 4 GRANTED

Related Keywords

skinvive derm wrinkles asymmetries conditions skin namely human defects facial treatment glabellar